Wuhan YZY Biopharma Co., Ltd. Report issue

For profit Phase 1
Founded: Wuhan China (2010)

Organization Overview

First Clinical Trial
2018
NCT04501770
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Wuhan YZY Biopharma Co., Ltd.